Journal of Neurology and Neuroscience

  • ISSN: 2171-6625
  • Journal h-index: 18
  • Journal CiteScore: 4.35
  • Journal Impact Factor: 3.75
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • The Global Impact Factor (GIF)
  • China National Knowledge Infrastructure (CNKI)
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Proquest Summons
  • Scientific Journal Impact Factor (SJIF)
  • Euro Pub
  • Google Scholar
  • Secret Search Engine Labs
Share This Page

Case Report - (2021) Volume 12, Issue 9

Guillain-Barre Syndrome during Post-Partum Period: A Rare Entity

Sandeep Ku Ratha1, Sumita Sharma2*and Srikant Ku Sahoo3

1Department of General Medicine, IMS & SUM Hospital, Siksha ‘O’ Anusandhan University, Bhubaneswar, Odisha, India

2Department of Community Medicine, IMS & SUM Hospital, Siksha ‘O’ Anusandhan University, Bhubaneswar, Odisha, India

3Department of Neurology, IMS & SUM Hospital, Siksha ‘O’ Anusandhan University, Bhubaneswar, Odisha, India

*Corresponding Author:
Sumita Sharma
Department of Community Medicine
IMS & SUM Hospital
Siksha ‘O’ Anusandhan University
Bhubaneswar, Odisha, India
Tel: + 7539022484

Received Date: June 26, 2021; Accepted Date: September 15, 2021; Published Date:September 22, 2021

Citation: Ratha SK, Sharma S, Sahoo SK (2021) Guillain-Barré Syndrome during Post-Partum Period: A Rare Entity. J Neurol Neurosci Vol.12 No.9:389

Visit for more related articles at Journal of Neurology and Neuroscience


Guillain–Barré Syndrome (GBS) is a serious post-infectious immune mediated neuropathy presented with diminished reflexes and resultant weakness. Global report on GBS depicted with an incidence of 1 to 4 cases per 100,000 annually and carries a high maternal risk. It is very rare among post-partum women. The study is case of 24 year women within 2 month of post-partum period who presented with flaccid quadriplegia diagnosed as GBS. The case is discussed in all the aspects of diagnosis, treatment and outcome.


Guillain–Barré syndrome; Post-partum


Guillain–Barré Syndrome (GBS) is otherwise known as Landry's paralysis [1]. It is a heterogenous group of immune mediated disorders of central nervous system manifested as acute inflammatory polyradiculoneuropathy with resultant weakness and areflexia with or without abnormal sensory function [2]. The symptoms of GBS are preceded by a pre-existing episode in about 66% of patients. There is evidence of association present between the disease and the conditions like bacterial and viral infections, systemic diseases, neoplasia, traumatic injury, and organ transplant etc. However, the association between GBS and pregnancy is very rare [3]. The incidence is 1 to 4 cases per 100,000 annually, with a high maternal risk. The study conducted by Kachru et al depicted that the risk of GBS increases in the postpartum period [1]. Most of the patients reports to physicians with the complain of paresthesias, numbness, or similar sensory changes. Paresthesia starts in the toes and fingertips, progressing upwards, but generally does not extend beyond the wrists or ankles. Here is the report of a unique case of GBS complicating pregnancy in the post-partum period. The patient recovered well with supportive measures and Intravenous Immunoglobulin (IVIG).

Case Report

A 33-year-old female, multigravida underwent caesarean section at term as she underwent c-section in her previous childbirth period. She stayed in hospital for 8 days and discharged to home on the 9th day with proper medication. After 45 days of post-operative procedure, the patient developed pain in lower limbs below the knee joints followed by numbness with tingling sensation in both hands and wrists, lower limbs below the knees and progressive weakness in the form of difficulty in buttoning and unbuttoning and combing hair, difficulty in standing from squatting position, difficulty in walking through staircase and then subsequently bedridden. Patient had similar type of illness 9 years. At that time she was in 1 month of post-partum period and due to the above symptoms she was diagnosed as AIDP, for which she had taken treatment with required dose of IVIG and completely recovered after 30 days of medication. On general examination, patient was conscious. There was no pallor, icterus, clubbing, cyanosis, edema, lymphadenopathy found. Her hydration status was normal. At the time of admission her vitals were within normal limit. During the period of hospitalization, complete neurological evaluation revealed bilateral limb weakness, areflexia, and graded sensory loss. She had progressive ascending paralysis with involvement of the lower limbs followed by upper limbs without bladder and bowel involvement. The respiratory system, autonomic system, and all her cranial nerves were normal. She presented with all features of the flaccid quadriplegia with grade three powers in both lower limbs and grade four power in upper limbs. There was decreased Muscle tone and deep tendon reflexes were lost. CBC with peripheral smear, kidney function test and liver function test and urinalysis were normal. Viral markers, venereal disease research laboratory, antiphospholipid antibodies (IgG and IgM) and lupus anticoagulant test were negative, and so were her Antinuclear Antibodies (ANA), rheumatoid factor (ANA), C-reactive protein. Thyroid function tests were within normal range. Magnetic resonance imaging was normal. Nerve conduction tests depicted as decreased conduction velocity and cerebrospinal fluid analysis revealed four cells/mm3 and protein of 80 mg/dl which is suggested diagnosis of GBS.


Her treatment was immediately started with IVIG 2 mg/kg, which was continued for 5 days. Her recovery was fast with improvement in muscle weakness. On day 7 of illness, she was discharged; she could walk with support and was advised physiotherapy. Power in the limbs gradually improved. She had little residual sequelae at 3 months follow-up post-partum. The patient gradually improved and recovered completely after 6 months.


The incidence of GBS is very low during pregnancy [4-6]. But the risk is increases in post-partum period [7]. It rarely gets complicated if associated with maternal and perinatal morbidity especially when the patient has not been treated properly [4]. The patient should be undergone proper investigations and adequate supportive measures by the clinicians. The cornerstone of management of GBS in postpartum period is access to IVIG therapy [8].

GBS is a neurological disorder resulting in muscle paralysis, which is symmetrical in nature [9]. Most of the patients are complaining with numbness, paresthesias, or other sensory changes. Paresthesias starts from the toes and fingertips, and then progresses upwards, but do not extend beyond the wrists or ankles [10].

The above study revealed that there was pain in both lower limb below knee joint. However other studies explained in various patients, the pain is most severe in the shoulder girdle, back, buttocks and thighs [11]. Studies shows pain occurs even with slightest movement. The nature of the pain is often described as throbbing or aching type [12].

Each and every age group people can be affected by GBS. The disease is vulnerable to both male as well as female equally. The exact cause of Guillain–Barre syndrome is unknown. Many researchers found that around 60% of GBS cases have followed a lung infection or a gastrointestinal infection [12]. The micro-organisms such as Campylobacter jejuni, influenza virus, cytomegalovirus, Epstein–Barr virus, mycoplasma, and HIV are strongly associated with GBS [13]. Patients with surgical history and anaesthesia may trigger the syndrome. Very few cases are reported due to vaccination entity [14].

The signs and symptoms of GBS remains over a period of hours, days or weeks. It has been noticed that most of the patients tend to reach the stage of highest weakness within the first 2 weeks after symptoms have started, and by the 3rd week of illness 90% of patients become get rid of the symptoms. The most typical manifestation of the disease begins with ascending paralysis [15]. The weakness starts in the feet, hands and migrating upwards to the trunk while some subtypes presented with change in sensation or pain and dysfunction of the autonomic nervous system.

GBS can be life-threatening, especially when the autonomous nervous system or respiratory muscles is involved. In severe cases of GBS, we found loss of autonomic function with wide fluctuations of blood pressure and sinus tachycardia even cardiac arrhythmias [11]. It can sometimes be really difficult to distinguish the symptoms of GBS from other nervous system disorders. The following two examinations are usually done to confirm the diagnosis [16]: a) Nerve conduction studies test that measure nerve b) Lumbar puncture test which shows a higher level of proteins with a normal cellular count.

During pregnancy or in post-partum period if GBS occurs, the risks of maternal mortality increase up to 7%. Around 20% patients are disabled within a period of 1 year [17]. After child birth, there is increase in cellular immunity and decrease in humoral immunity, which is due to the pro-inflammatory cytokine surge in the postpartum period [18]. The study conducted by Fernando MS, et al. [10] shows the worsen condition of GBS in the post-partum period due to increase in delayed type of hypersensitivity. Similarly another study conducted by Silva CF, et al. [19] had mentioned a case of GBS, which was diagnosed at 15 weeks of pregnancy and aggravated in the postpartum period [20].

In view of the evidence of immune dysfunction in GBS, the favourable outcome with full recovery has been seen in 70-80% of patients those have been treated with plasma exchange and Intravenous Immunoglobulin (IVIG) [20]. Earlier the IVIG was introduced for the treatment of auto-immune thrombocytopaenia and chronic inflammatory demyelinating polyneuropathy. The role of IVIG in GBS was reported in 1988 which led to the first randomized controlled trial. Various studies including metaanalysis resulted with higher efficacy and cost effectiveness of IVIG therapy in GBS. The randomized control trials show IVIG has lesser adverse effect, hence preferred over plasma exchange therapy.

The study conducted by Bahadur A, et al. [10] reported a 25-yearold multigravida at 21 weeks of pregnancy with successful maternal and fetal outcome. Similar study carried out by Goyal et al. found to be Successful management of a primigravida presenting at 26 weeks’ gestation with plasmapheresis.

Our case is quite different from other studies as the case was reported to us after 45 days of post-partem period and by administration of IVIG in the mean-time the case was successfully recovered. Clinicians should have a high index of suspicion in the case during pregnancy as well as after child birth during postpartum period complaining of muscle weakness, general malaise, tingling sensation over fingers and breathlessness in the context of a recent diarrheal episodes or viral infection. An early diagnosis with multi-disciplinary supportive measures helps in improving the prognosis for both the mother and the foetus.



  1. Kachru C, Bahadur A, Dagar M, Agrawal R. (2015) Diagnosing GulliannBarre syndrome in the post-partum period: A case report. J Med ScinHeal 1: 21–23.
  2. Pakhale SW, Sehra A, Bhardwaj S (2020) Guillain-Barre syndrome innpregnancy- A rare entity. Int J Reprod Contraception. Obstet Gynecoln9: 4734.
  3. Hukuimwe M, Matsa TT, Gidiri MF (2017) Guillain-Barré syndrome innpregnancy: A case report. Womens Health (Lond Engl) 13: 10–13.
  4. Meenakshi-Sundaram S, Swaminathan K, Karthik SN, BharathinS (2014) Relapsing Guillain-Barre syndrome in pregnancy andnpostpartum. Ann Indian Acad Neurol 17: 352–354.
  5. Guillain-Barré syndrome in pregnancy - PubMed [Internet]. [citedn2021 May 26]. Available from: https://pubmed.ncbi.nlm.nih.ngov/15005776/
  6. Vijayaraghavan J, Vasudevan D, Sadique N, Rajeswari KS, PonduranginM (2006) A rare case of guillain-barre syndrome with pregnancy. JnIndian Med Assoc 104: 269–270.
  7. Sharma SR, Sharma N, Masaraf H, Singh SA (2015) Guillain-Barrénsyndrome complicating pregnancy and correlation with maternalnand fetal outcome in North Eastern India: A retrospective study. AnnnIndian Acad Neurol 18: 215–218.
  8. Perez EE, Orange JS, Bonilla F, Chinen J, Chinn IK, et al. (2017)nUpdate on the use of immunoglobulin in human disease: A review ofnevidence. J Allergy Clin Immunol 139: 1–46.
  9. Guillain-Barré Syndrome Fact Sheet | National Institute ofnNeurological Disorders and Stroke [Internet]. [cited 2021 May 26].nAvailable from:é-Syndrome-Fact-nSheet
  10. Fernando MS, Ambanwala AS, Ranaweera P, Kaluarachchi A (2016)nGuillain-Barré syndrome in pregnancy: A conservatively managedncase. J Fam Med Prim care 5: 688–690.
  11. Newswanger DL, Warren CR (2004) Guillain-Barré syndrome.nAmerican Family Physician 69: 2405–2410.
  12. What is the typical presentation of pain in Guillain-Barre syndromen(GBS)? [Internet]. [cited 2021 May 26]. Available from:
  13. Tam CC, O’Brien SJ, Rodrigues LC (2006) Influenza, Campylobacternand Mycoplasma infections, and hospital admissions for Guillain-nBarré syndrome, England. Emerg Infect Dis 12: 1880–1887.
  14. Wajih Ullah M, Qaseem A, Amray A (2018) Post Vaccination GuillainnBarre syndrome: A case report. Cureus 10: e2511
  15. Dimachkie MM, Barohn RJ (2013) Guillain-Barré syndrome andnvariants. Neurol Clin 31: 491–510.
  16. Guillain-Barre Syndrome workup: Approach considerations,nperipheral neuropathy workup, biochemical screening. Availablenfrom:
  17. Singh N, Perfect JR (2007) Immune reconstitution syndrome andnexacerbation of infections after pregnancy. Clin Infect Dis 45: 1192–n1199.
  18. Silva CF, Paula DG, Automari CV, Almeida DS, Guimarães UR (2009)nGuillain-barré syndrome in pregnancy: Early diagnosis and treatment isnessential for a favorable outcome. Gynecol Obstet Invest 67: 236–237.
  19. Doorn PA, Kuitwaard K, Walgaard C, van Koningsveld R, Ruts L, et al.n(2010) IVIG treatment and prognosis in Guillain-Barré syndrome. JnClin Immunol 74–78.
  20. Doorn PA, Kuitwaard K, Walgaard C, van Koningsveld R, Ruts L, et al.n(2010) IVIG treatment and prognosis in Guillain-Barré syndrome. JnClin Immunol 74–78.